A Telehealth Advance Care Planning Intervention
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 60 lat lub więcej
- •Diagnoza: ostra białaczka szpikowa, zespół mielodysplastyczny lub podobne nowotwory szpiku
- •Pacjent leczony ambulatoryjnie (nie w szpitalu)
- •Możliwość wyrażenia świadomej zgody na udział
- •Posługiwanie się językiem angielskim
- •Opiekun lub bliski wyznaczony przez pacjenta - wiek 18 lat lub więcej
- •Lekarz onkolog prowadzący badanie przez internet
Simplified criteria — AI translation
Trial details
- Minimum age
- 60 Years
- Last updated (source)
- September 11, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Rochester
Rochester, United States
Trial contact
Kah Poh Loh, MD
Becky Gravenstede
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.